<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35648369</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2095-0225</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Frontiers of medicine</Title><ISOAbbreviation>Front Med</ISOAbbreviation></Journal><ArticleTitle>Increased expression of coronin-1a in amyotrophic lateral sclerosis: a potential diagnostic biomarker and therapeutic target.</ArticleTitle><Pagination><StartPage>723</StartPage><EndPage>735</EndPage><MedlinePgn>723-735</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11684-021-0905-y</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. At present, no definite ALS biomarkers are available. In this study, exosomes from the plasma of patients with ALS and healthy controls were extracted, and differentially expressed exosomal proteins were compared. Among them, the expression of exosomal coronin-1a (CORO1A) was 5.3-fold higher than that in the controls. CORO1A increased with disease progression at a certain proportion in the plasma of patients with ALS and in the spinal cord of ALS mice. CORO1A was also overexpressed in NSC-34 motor neuron-like cells, and apoptosis, oxidative stress, and autophagic protein expression were evaluated. CORO1A overexpression resulted in increased apoptosis and oxidative stress, overactivated autophagy, and hindered the formation of autolysosomes. Moreover, CORO1A activated Ca<sup>2+</sup>-dependent phosphatase calcineurin, thereby blocking the fusion of autophagosomes and lysosomes. The inhibition of calcineurin activation by cyclosporin A reversed the damaged autolysosomes. In conclusion, the role of CORO1A in ALS pathogenesis was discovered, potentially affecting the disease onset and progression by blocking autophagic flux. Therefore, CORO1A might be a potential biomarker and therapeutic target for ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. Higher Education Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Qinming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hu</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, the First Hospital of Jiaxing &amp; the Affiliated Hospital of Jiaxing University, Jiaxing, 314000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yining</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dingding</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Co-innovation Center of Neuroregeneration, Nantong University, Nantong, 226007, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>You</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yuening</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The People's Hospital of Rushan, Weihai, 264500, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Huafeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xinrui Hospital, Wuxi, 214000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. jly0520@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Weidong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Neurology, Sichuan Academy of Medical Sciences-Sichuan Provincial Hospital, Chengdu, 610072, China. wdle@sibs.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. mztcs@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Co-innovation Center of Neuroregeneration, Nantong University, Nantong, 226007, China. mztcs@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Front Med</MedlineTA><NlmUniqueID>101549428</NlmUniqueID><ISSNLinking>2095-0217</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="D019703">Calcineurin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008840">Microfilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003598">Cytoskeletal Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019703" MajorTopicYN="N">Calcineurin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008840" MajorTopicYN="N">Microfilament Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003598" MajorTopicYN="N">Cytoskeletal Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">coronin-1a</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35648369</ArticleId><ArticleId IdType="doi">10.1007/s11684-021-0905-y</ArticleId><ArticleId IdType="pii">10.1007/s11684-021-0905-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH. Amyotrophic lateral sclerosis. Lancet 2017; 390(10107): 2084&#x2013;2098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T, Al Khleifat A, Meurgey JH, Jones A, Leigh PN, Bensimon G, Al-Chalabi A. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol 2018; 17(5): 416&#x2013;422</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId><ArticleId IdType="pmc">5899963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med Res Rev 2019; 39(2): 733&#x2013;748</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Liu Y, Liu X, Li S, Cheng C, Chen S, Le W. Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model. Transl Neurodegener 2018; 7(1): 35</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0138-4</ArticleId><ArticleId IdType="pubmed">30607245</ArticleId><ArticleId IdType="pmc">6309063</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Gendron TF, Staff NP. Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 2018; 93(11): 1617&#x2013;1628</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA ALS genetics, mechanisms, and therapeutics: where are we now?. Front Neurosci 2019; 13: 1310</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId><ArticleId IdType="pmc">6909825</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011; 7(11): 639&#x2013;649</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Gao Y, Lin X, Li L, Han X, Liu J. The coronin family and human disease. Curr Protein Pept Sci 2016; 17(6): 603&#x2013;611</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203717666151201192011</ArticleId><ArticleId IdType="pubmed">26916159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 1999; 97(4): 435&#x2013;447</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80754-0</ArticleId><ArticleId IdType="pubmed">10338208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ML. Coronin-1, king of alloimmunity. Immunity 2019; 50(1): 3&#x2013;5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.12.030</ArticleId><ArticleId IdType="pubmed">30650379</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Zhang X, Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy 2008; 4(3): 290&#x2013;293</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5524</ArticleId><ArticleId IdType="pubmed">18196963</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1(5): 293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Pu C, Fan D. Chinese guidelines for diagnosis and treatment of amyotrophic lateral sclerosis. Chin J Neurol (Zhonghua Shen Jing Ke Za Zhi) 2012; 45(7): 531&#x2013;533 (in Chinese)</Citation></Reference><Reference><Citation>Kraemer M, Buerger M, Berlit P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2010; 112(2): 103&#x2013;105</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2009.10.014</ArticleId><ArticleId IdType="pubmed">19931253</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Shen D, Gao Y, Zhou Q, Ni Y, Meng H, Shi H, Le W, Chen S, Chen S. A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed? Transl Neurodegener 2021; 10(1): 29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00250-5</ArticleId><ArticleId IdType="pubmed">34372914</ArticleId><ArticleId IdType="pmc">8353789</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensel N, Claus P. The actin cytoskeleton in SMA and ALS: how does it contribute to motoneuron degeneration? Neuroscientist 2018; 24(1): 54&#x2013;72</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858417705059</ArticleId><ArticleId IdType="pubmed">28459188</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberstadt M, Cla&#xdf;en J, Arendt T, Holzer M. TDP-43 and cytoskeletal proteins in ALS. Mol Neurobiol 2018; 55(4): 3143&#x2013;3151</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0543-1</ArticleId><ArticleId IdType="pubmed">28466273</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L, Le W. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy 2014; 10(4): 588&#x2013;602</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.27710</ArticleId><ArticleId IdType="pubmed">24441414</ArticleId><ArticleId IdType="pmc">4091147</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou QM, Zhang JJ, Li S, Chen S, Le WD. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1<sup>G93A</sup> mouse model of amyotrophic lateral sclerosis. CNS Neurosci Ther 2017; 23(5): 375&#x2013;385</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12681</ArticleId><ArticleId IdType="pubmed">28229532</ArticleId><ArticleId IdType="pmc">6492644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJ, Zhou QM, Chen S, Le WD. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model. CNS Neurosci Ther 2018; 24(12): 1163&#x2013;1174</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12855</ArticleId><ArticleId IdType="pubmed">29656576</ArticleId><ArticleId IdType="pmc">6489874</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorella M, Barford K, Winkler B, Deppmann CD. Emergent role of coronin-1a in neuronal signaling. Vitam Horm 2017; 104: 113&#x2013;131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.vh.2016.10.002</ArticleId><ArticleId IdType="pubmed">28215292</ArticleId></ArticleIdList></Reference><Reference><Citation>Suo D, Park J, Harrington AW, Zweifel LS, Mihalas S, Deppmann CD. Coronin-1 is a neurotrophin endosomal effector that is required for developmental competition for survival. Nat Neurosci 2014; 17(1): 36&#x2013;45</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3593</ArticleId><ArticleId IdType="pubmed">24270184</ArticleId></ArticleIdList></Reference><Reference><Citation>BoseDasgupta S, Pieters J. Coronin 1 trimerization is essential to protect pathogenic mycobacteria within macrophages from lysosomal delivery. FEBS Lett 2014; 588(21): 3898&#x2013;3905</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.08.036</ArticleId><ArticleId IdType="pubmed">25217836</ArticleId></ArticleIdList></Reference><Reference><Citation>Seto S, Tsujimura K, Koide Y. Coronin-1a inhibits autophagosome formation around Mycobacterium tuberculosis-containing phagosomes and assists mycobacterial survival in macrophages. Cell Microbiol 2012; 14(5): 710&#x2013;727</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2012.01754.x</ArticleId><ArticleId IdType="pubmed">22256790</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayachandran R, Pieters J. Regulation of immune cell homeostasis and function by coronin 1. Int Immunopharmacol 2015; 28(2): 825&#x2013;828</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2015.03.045</ArticleId><ArticleId IdType="pubmed">25882105</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayachandran R, Sundaramurthy V, Combaluzier B, Mueller P, Korf H, Huygen K, Miyazaki T, Albrecht I, Massner J, Pieters J. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 2007; 130(1): 37&#x2013;50</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.04.043</ArticleId><ArticleId IdType="pubmed">17632055</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong Y, Song F. Intracellular calcium signaling regulates autophagy via calcineurin-mediated TFEB dephosphorylation. Autophagy 2015; 11(7): 1192&#x2013;1195</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1054594</ArticleId><ArticleId IdType="pubmed">26043755</ArticleId><ArticleId IdType="pmc">4590610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YX, Han XS, Jing Q. Ca(2+) ion and autophagy. In: Qin ZH. Autophagy: Biology and Diseases. Advances in Experimental Medicine and Biology, vol 1206. Singapore: Springer, 2019: 151&#x2013;166</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-0602-4_7</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>